NCT05721144View on ClinicalTrials.gov

Inhaled NO in Surgical Patients With Recent COVID-19 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

April 14, 2024

Study Completion Date

May 7, 2024

Conditions
Nitric OxideCOVID-19SurgeryPostoperative Complications
Interventions
DRUG

Nitric Oxide Gas

Inspired NO/N2 will be delivered at 80 parts per million (ppm) after anesthesia induction and intubation and lasted until the end of surgery and leave the operating room.

Trial Locations (1)

710032

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER